February 2, 2009 - Diagnosoft Inc. has unveiled its newest software solution, the Diagnosoft SENC. Strain-encoding (SENC). SENC is a new MRI analysis technique that will help physicians measure regional contraction, or relaxation, of the heart's myocardium. Like Diagnosoft's other two software products, Diagnosoft HARP and Diagnosoft PLUS, Diagnosoft SENC enables quantification of data to improve diagnosis and guide monitoring and treatment of coronary artery disease. Developed by Nael Osman, M.D., a faculty member at Johns Hopkins University, SENC is now a proprietary product of Diagnosoft Inc. According to Dr. Osman, co-founder of Diagnosoft, "Diagnosoft SENC provides an objective way to assess regional variations in muscle contraction due to ischemia, myocardial infarction, or other causes. Moreover, Diagnosoft SENC produces maps of regional function with high spatial resolution at a level of quality sufficient even for the thin wall of the right ventricle. As a result, the technique can reveal small regional anomalies in contractility within the wall." Most cardiac MRI procedures require patients to hold their breath. However, SENC images can be acquired in a fraction of a second, mapping regional function with unprecedented speed, so it can be used in combination with tests and maneuvers that allow patients to breathe normally. That means SENC is suitable for stress testing of cardiac function, as well as other diagnostic tests. Dr. Osman said new Diagnosoft SENC is a great addition to a rich and unique product suite originated with Diagnosoft HARP, "While MR tagged images can be produced on most MRI systems, this pulse sequence has limited spatial resolution and takes time to acquire. SENC pulse sequence does not require a second step of image processing, as does analyzing tagged MR images, so it streamlines throughput and decision-making." For more information: www.diagnosoft.com
Technology | February 02, 2009
Diagnosoft Releases Its Third MRI Analysis Innovation
Feature | Magnetic Resonance Imaging (MRI) | February 28, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
News | Magnetic Resonance Imaging (MRI) | February 27, 2018
A new study published in the Journal of the American College of Cardiology confirms non-invasive cardiac magnetic...
Technology | Magnetic Resonance Imaging (MRI) | February 12, 2018
February 12, 2018 — Physicians now have access to more neuro and cardiac ...
News | Magnetic Resonance Imaging (MRI) | January 25, 2018
January 25, 2018 – Canon Medical Systems, in partnership with
News | Magnetic Resonance Imaging (MRI) | January 16, 2018
January 16, 2018 — Researchers from the NUST MISIS Engineering Center for Industrial Technologies in Russia have deve
Videos | Magnetic Resonance Imaging (MRI) | December 13, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pitt
Technology | Magnetic Resonance Imaging (MRI) | December 13, 2017
GE Healthcare announced U.S. FDA 510(k) clearance of its new Air Technology, what it calls an industry-first suite of...
Technology | Magnetic Resonance Imaging (MRI) | December 11, 2017
Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition with the all-new Saturn X...
Technology | Magnetic Resonance Imaging (MRI) | December 05, 2017
Toshiba Medical, a Canon Group company, introduced its newest magnetic resonance (MR) system, the Vantage Elan/Zen...
Technology | Magnetic Resonance Imaging (MRI) | October 12, 2017
The U.S. Food and Drug Administration (FDA) cleared the first 7 Tesla (7T) magnetic resonance imaging (MRI) device,...